Organization
Azienda Ospedaliero-Universitaria San Luigi Gonzaga
1 abstract
Abstract
Trastuzumab deruxtecan (T-DXd) in patients with HER2-mutant metastatic non–small cell lung cancer (mNSCLC): Final analysis results of DESTINY-Lung02.Org: Nantes University Hospital Center, Azienda Ospedaliero-Universitaria San Luigi Gonzaga,